Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunex -- Ignore unavailable to you. Want to Upgrade?

To: LemurHouse who wrote (378)	11/8/1999 9:30:00 AM
From: LemurHouse	Read Replies (1) \| Respond to of 656

Also, the ACR (American College of Rheumatology) conference starts on Friday in Philadelphia. IMNX will be presenting a lot of Enbrel data, including juvenile RA and early RA treatments. We should be looking at a good run over the next week or ten days. EDIT: Just a couple of minutes ago, Phil Orlando on CNBC mentioned IMNX first as his best buys in biotech. Not much in and of itself, but its nice that the company is getting some visibility.